SUMMARY
The perioperative mortality score aims to predict mortality in elderly patients undergoing noncardiac surgery using three preoperative risk factors (age, albumin and American Society of Anesthesiologists physical status) and then modify this risk assessment if any of three postoperative complications occur (unplanned intensive care unit admission, systemic inflammation and acute renal failure). In order to determine the cost of routine perioperative mortality score calculation in future research, we audited the incidence of clinician-initiated preoperative albumin, pre-and postoperative creatinine and postoperative white cell count testing in patients aged ≥70 years presenting for elective and emergency noncardiac surgery requiring at least overnight admission over a three-month period. We recruited 637 noncardiac surgical patients. All laboratory tests required for perioperative mortality score calculation were performed in only 47% of patients and the total cost of testing all untested patients was A$12,057 (A$18,927 per 1000 patients). Preoperative hypoalbuminaemia was present in 11% of tested patients, acute renal impairment in 24% of tested patients and high white cell count in 33% of tested patients. These results may be used to inform future research or clinical use of the score.
In clinical use, the POM score uses points as they become available in a cumulative fashion. For audit and research purposes, the complete POM score cannot be calculated unless the six data points are collected. Age and ASA physical status are routinely recorded in operating theatre databases. Unplanned ICU admission and sepsis are recorded as part of coding procedures postoperatively. However, although preoperative creatinine is commonly measured in elderly patients, preoperative serum albumin and postoperative serum creatinine are not routinely measured, and a raised white cell count is frequently required in order to establish the diagnosis of sepsis. Further validation studies or research using the score, or indeed use of the score in clinical practice, will therefore required additional testing and cost.
Therefore, as an aid to those considering further research with or clinical use of the POM score, we audited the incidence of preoperative albumin, pre-and postoperative creatinine and postoperative white cell count testing in patients aged ≥70 years presenting for elective and emergency noncardiac surgery requiring at least overnight admission over a three-month period. Our primary aims were: 1) to determine the percentage of patients aged ≥70 years presenting for elective and emergency noncardiac surgery who had the necessary laboratory investigations for calculation of the POM score, and 2) to determine potential costs of instituting measurement to enable calculation of POM scores in the "untested" patients.
METHODS
Ethics committee approval was obtained from the Royal Melbourne Hospital (a metropolitan teaching hospital) and Ballarat Base Hospital (a regional base hospital) before data collection commenced. As this activity constituted an audit, the requirement for patient consent was waived at both centres.
The hospital identification numbers, dates of birth and admission and discharge dates of all patients having surgery during July, August and September of 2009 were obtained from operating room records. The inclusion criteria for the study were: 1) age ≥70 years; 2) surgery undertaken in the main operating suite of the hospital; 3) overnight stay in the hospital following surgery and 4) noncardiac surgery. Patients not meeting these criteria and those having gastrointestinal endoscopy in the main operating suite were excluded.
Once the study cohort was finalised, the following information was obtained from each hospital's databases: 1) ASA physical status; 2) type of surgery; 3) elective or emergency status; 4) preoperative serum albumin concentration (measured on the day closest to surgery and within three months of operative day); 5) preoperative serum creatinine concentration (measured on the day closest to surgery and within three months of operative day); 6) postoperative serum creatinine concentrations (measured before hospital discharge, all recorded values) and 7) postoperative white cell counts (measured before hospital discharge, all recorded values). Hypoalbuminaemia was defined as a serum albumin <30 g/l. Acute renal impairment was defined as an increase in serum creatinine more than 20% above the preoperative value. An increased white cell count was defined as >12,000 cells/μl. The cost of measuring albumin, creatinine and white cell count was defined using the Australian Commonwealth Medical Benefits Schedule (A$17.80 for the panel including albumin and for the panel including creatinine; A$17.05 for the panel including white cell count). The cost per 1000 patients was also calculated.
Continuous data were graphed to assess their distributions. As all continuous data were skewed, the data were summarised using median (range) and compared using the Wilcoxon rank-sum test. Analyses were conducted using Stata 10.1 (Stata Corporation, College Station, TX, USA). All P values are two-sided and P <0.05 was considered statistically significant.
RESULTS
A total of 637 patients were included in the study (426 [67%] from the Royal Melbourne Hospital and 221 [33%] from the Ballarat Base Hospital). Patients were aged 77 (70 to 96) years, 53% were male, 60% were ASA physical status 3 to 5 and 37% underwent emergency surgery.
Albumin was measured preoperatively in 358 patients (56%). Creatinine was measured preoperatively in 543 patients (85%) and postoperatively in 484 patients (76%). White cell counts were measured postoperatively in 479 patients (75%). Only 47% of patients had all laboratory testing required to calculate the POM score (i.e. preoperative albumin and creatinine and postoperative creatinine and white cell count).
The estimated cost of conducting these tests in untested patients was A$4966 for preoperative albumin (n=279; A$7796 per 1000 patients), $1673 for preoperative creatinine (n=94; A$2627 per 1000 patients), A$2723 for at least one postoperative creatinine (n=153; A$4275 per 1000 patients) and A$2694 for at least one postoperative white cell count (n=158; A$4229 per 1000 patients). The total cost for both hospitals of testing all untested patients was $12,057 (A$18,927 per 1000 patients).
Hypoalbuminaemia was present in 40 preoperative patients (11%) with available preoperative albumin measurement. The incidence of hypoalbuminaemia was higher among tested emergency patients than tested elective patients ( Table 2) . Acute renal impairment developed in 105 patients with pre-and postoperative creatinine measurements (22%). A high white cell count was detected in 159 of patients in whom white cell count was measured postoperatively (33%).
DISCUSSION
Our study of 637 noncardiac surgical patients aged ≥70 years demonstrated that all laboratory tests required for POM score calculation were performed in only 47% of patients and that the total cost for both hospitals of testing all untested patients was A$12,057 (A$18,927 per 1000 patients). These results may be used to inform future research or clinical use of the score. Abnormal test results were common in tested patients with preoperative hypoalbuminaemia present in 11% of tested patients, acute renal impairment in 24% of tested patients and high white cell count in 33% of tested patients.
A minority of patients in our audit had all the tests required to calculate the POM score. The main reason for failure of complete testing was lack of preoperative albumin measurement. Much evidence exists regarding the prognostic value of hypoalbuminaemia in medical conditions, such as malignancy, liver and renal disease, sepsis and pre-eclampsia. Preoperatively, hypoalbuminaemia acts as a nonspecific marker of chronic disease or malnutrition and therefore worse outcome 6, 7 . However, its under-utilisation as a preoperative marker of poorer prognosis is not surprising when the prevailing ethos of preoperative assessment emphasises a clinical assessment of cardiovascular fitness for surgery 8 . Based on the proven prognostic value of albumin in the perioperative period 1-3 , we believe that preoperative albumin should be measured in all elderly patients regardless of whether risk scoring is contemplated.
Abnormal test results were common in our patient population. Preoperative hypoalbuminaemia was present in 11% of tested patients and acute postoperative renal impairment was frequently detected (22% of tested patients). Both were more commonly encountered in emergency patients than elective patients, which is consistent with the higher rates of comorbidity and increased surgical complexity in these patients. However, all these results should be interpreted with caution as testing was not protocolised and the incidences in untested patients are unknown.
The total cost of testing all untested patients was A$12,057 (A$18,927 per 1000 patients). The greatest additional expense would accrue from universal measurement of preoperative albumin (A$4966 [A$7796 per 1000 patients]). These results could be used in planning a further evaluation study or clinical use of the score. For ease of comparison, our costings are based on Medicare reimbursement, which may be discounted to a greater or lesser extent in Australian public hospitals. In addition, the cost of additional tests when several tests are already ordered (e.g. adding albumin to urea, creatinine and electrolytes) is actually less than when ordering the test alone. Finally, we have not included the labour costs of collecting the samples, which vary greatly according to the variety of tests ordered in each patient. The overall cost of additional testing therefore may be less than quoted in this paper.
The strength of our audit lies in the comprehensiveness with which we were able to collect data for the laboratory testing components of the POM score. Via our database records, we were able to audit every elderly patient who underwent surgery requiring at least overnight admission in a three-month period. We also audited the ordering of laboratory tests and calculated what proportion of patients was actually being tested in a reliable way. This exercise revealed that laboratory testing in both hospitals was often a relatively 'ad hoc' process. There were not only omissions but multiple duplications so that the cost of testing untested patients for one or other variable could readily be recouped by limiting the frequency of repeat testing of variables that are unlikely to change on a daily basis.
The two other POM score variables (namely the clinical findings that define systemic inflammation and the incidence of unplanned ICU admission) were beyond the scope of our electronic audit as in our hospitals this would have required a detailed chart review of every patient. Furthermore, we did not measure postoperative mortality or complications and therefore cannot estimate whether the increased cost of testing could be justified on the basis of reduced postoperative cost because of better risk stratification. This requires a sophisticated costbenefit analysis. Finally, we included the laboratory test measured on the day closest to surgery and within three months of the operative day, because this represented the typical timeframe of attendance at preoperative clinics in our hospitals. However, 90% of patients had an albumin measurement within one month of surgery, and albumin, as a chronicphase indicator of health status, does not change rapidly (except in acute illness where it is likely to be re-measured).
In conclusion, our audit revealed that current laboratory testing in elderly patients undergoing noncardiac surgery in our hospitals was not adequate to enable routine calculation of the POM score in 53% of patients. This represents a significant barrier to retrospective research using the POM score and prospective estimation of risk in individual patients. The costs of additional testing need to be taken into account in the planning of further validation studies or clinical use of the score. Based on the National Surgical Quality Improvement Program 2,3 and REASON 1 studies, preoperative albumin should be tested routinely in elderly surgical patients.
